$TER

Smith Gregory Stephen sold $1.7M of TER

Smith Gregory Stephen (President and CEO) sold 4,000 shares of TERADYNE, INC (TER) at $423.03 ($1.69M total) on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Smith Gregory Stephen
Published Jun 16, 2026, 9:57 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 16, 2026, 10:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TER
Neutral
medium confidence
Mentioned
$TER
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TERNeutralLow
01

Why it matters

The disclosure adds a fresh, timestamped data point on insider activity, but it does not include any new company fundamentals (earnings, guidance, contracts, or regulatory actions).

02

Market read

Insider selling can influence short-term sentiment, but 10b5-1 context usually limits trading impact absent other catalysts.

03

What to watch

Traders may ignore that the CEO’s holdings remain substantial (120,470 shares after sale), and that the article provides no accompanying guidance, performance, or legal/product developments.

Relevance 5/10Novelty 8/10Timing: SEC Form 4 filed June 16 for a June 15 sale

Background

The article reports an SEC Form 4 insider transaction for Teradyne, Inc. (TER) by its President and CEO.

Company-level read

Ticker impact

$TERNeutralMedium confidence
Context

Teradyne CEO Smith Gregory Stephen sold 4,000 shares on a pre-arranged 10b5-1 plan for about $1.69M, per Form 4 filed June 16.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is primary-source and time-stamped, but the sale is explicitly under a pre-arranged 10b5-1 plan, which reduces interpretive weight versus discretionary selling.

Market effects

Minimal; this is company-specific insider transaction with no stated operational or sector catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is on a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish fundamentals—so any negative read-through could be overdone.

Key entities

  • TERADYNE, INC

    US-listed company whose CEO filed an SEC Form 4 insider sale.

  • Smith Gregory Stephen

    President and CEO who sold 4,000 shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FORMMedAI 8/10

FormFactor, Entegris, Penguin Solutions, Teradyne, and Marvell Technology Stocks Trade Up, What You Need To Know

Several semiconductor stocks rose after the August jobs report, which showed 162,000 nonfarm payroll jobs added, beating estimates. Despite initial expectations of a rate hike, traders rotated back into the chip sector. FormFactor (FORM) +5.3%, Entegris (ENTG) +5.6%, Penguin Solutions (PENG) +5.1%, Teradyne (TER) +4.8%, and Marvell Technology (MRVL) +6.2%. Marvell reported Q2 revenue of $2.74B, up 36.5% YoY, with strong Data Center demand. Management guided Q3 revenue at $3.15B, but revenue from

$TERMed

Teradyne Stock Plunges 15% in a Month: Should You Buy the Dip?

Teradyne (TER) shares fell 15.4% in a month, underperforming peers and sector. Challenges include customer concentration and muted demand, but AI-driven data center growth and strong Q3 guidance offset this. TER expects $1.20-$1.30B revenue and $1.85-$2.15 EPS for Q3 2026, up significantly YoY. The stock trades at a premium with a forward P/S of 9.35X.

$TERHigh

Why is Teradyne stock sliding today?

Teradyne (TER) stock fell 3.9% after Baird downgraded it to Neutral with a $420 price target, citing stretched valuation and concerns over AI and hyperscaler spending sustainability. The firm argues GPU testing catalyst is priced in and next growth drivers are too distant. TER's decline contrasts with broader market gains, highlighting company-specific pressures.

$METAMed

Stocks making the biggest moves midday: Meta, Amylyx, Baidu, Klarna, Coherent, Sandisk & more

Amylyx Pharmaceuticals shares rose 53% after its avexitide treatment met trial endpoints. Meta Platforms fell 3% amid a lawsuit. Carvana dropped 3% after director stock sales. UGI Corporation surged 12% on a $9B KKR bid report. AI-related stocks declined. Klarna fell 21% on weak guidance. Baidu dropped 12% on earnings miss. Home Depot rose slightly on earnings beat. Fabrinet fell 20% on margin concerns. Memory stocks declined. Duolingo rose 7% on an upgrade.